Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

L-DOPA

Product Specifications

UNSPSC Description

L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease[1][2][3].

Target Antigen

Dopamine Receptor; Endogenous Metabolite

Type

Natural Products

Related Pathways

GPCR/G Protein;Metabolic Enzyme/Protease;Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease; Cancer

Assay Protocol

https://www.medchemexpress.com/L-DOPA.html

Purity

99.98

Solubility

0.1 M HCL : 20 mg/mL (ultrasonic;warming;adjust pH to 2 with HCl;heat to 60°C)|DMSO : 2 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 1 mg/mL (ultrasonic)

Smiles

N[C@@H](CC1=CC(O)=C(C=C1)O)C(O)=O

Molecular Weight

197.19

References & Citations

[1]Hyland K, et al. Aromatic L-amino acid decarboxylase deficiency: diagnostic methodology. Clin Chem. 1992 Dec;38(12):2405-10.|[2]Merims D, et al. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord. 2008;14(4):273-80. Epub 2007 Nov 7.|[3]Perez-Pardo P, et al. Additive Effects of Levodopa and a Neurorestorative Diet in a Mouse Model of Parkinson's Disease. Front Aging Neurosci. 2018 Aug 3;10:237.|[4]Park HJ, et al. Anti-allodynic effects of levodopa in neuropathic rats. Yonsei Med J. 2013 Mar 1;54(2):330-5.|[5]M Lundblad, et al. Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. Exp Neurol. 2005 Jul;194(1):66-75. |[6]Jie Zhang, et al. Pharmacokinetics of L-dopa in plasma and extracellular fluid of striatum in common marmosets. Brain Res. 2003 Dec 12;993(1-2):54-8.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, stored under nitrogen)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-N0304/L-DOPA-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-N0304/L-DOPA-SDS-MedChemExpress.pdf

Clinical Information

Launched

CAS Number

59-92-7

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MAP1 antibody
70R-MR048 100 ug

MAP1 antibody

Ask
View Details
WDR78 Overexpression Lysate (Native) - (Dry Ice)
NBP2-06288 0.1 mg

WDR78 Overexpression Lysate (Native) - (Dry Ice)

Ask
View Details
Bst1 Rat shRNA Plasmid (Locus ID 81506)
TR711091 1 Kit

Bst1 Rat shRNA Plasmid (Locus ID 81506)

Ask
View Details